These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

441 related articles for article (PubMed ID: 29351776)

  • 41. Changes in coding of pneumonia and impact on the Hospital Readmission Reduction Program.
    Buxbaum JD; Lindenauer PK; Cooke CR; Nuliyalu U; Ryan AM
    Health Serv Res; 2019 Dec; 54(6):1326-1334. PubMed ID: 31602637
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Readmission Rates for Chronic Obstructive Pulmonary Disease Under the Hospital Readmissions Reduction Program: an Interrupted Time Series Analysis.
    Buhr RG; Jackson NJ; Kominski GF; Dubinett SM; Mangione CM; Ong MK
    J Gen Intern Med; 2020 Dec; 35(12):3581-3590. PubMed ID: 32556878
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Variation in readmission rates among hospitals following admission for traumatic injury.
    Osler T; Yuan D; Holden J; Huang Z; Cook A; Glance LG; Buzas JS; Hosmer DW
    Injury; 2019 Jan; 50(1):173-177. PubMed ID: 30170786
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Excess Readmission vs Excess Penalties: Maximum Readmission Penalties as a Function of Socioeconomics and Geography.
    Caracciolo C; Parker D; Marshall E; Brown J
    J Hosp Med; 2017 Aug; 12(8):610-617. PubMed ID: 28786426
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Contextual, organizational and ecological effects on the variations in hospital readmissions of rural Medicare beneficiaries in eight southeastern states.
    Wan TT; Ortiz J; Du A; Golden AG
    Health Care Manag Sci; 2017 Mar; 20(1):94-104. PubMed ID: 26373554
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Trends in 30-Day Readmission Rates for Medicare and Non-Medicare Patients in the Era of the Affordable Care Act.
    Angraal S; Khera R; Zhou S; Wang Y; Lin Z; Dharmarajan K; Desai NR; Bernheim SM; Drye EE; Nasir K; Horwitz LI; Krumholz HM
    Am J Med; 2018 Nov; 131(11):1324-1331.e14. PubMed ID: 30016636
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Indication for Lower Extremity Revascularization and Hospital Profiling of Readmissions.
    Gonzalez AA; Cruz CG; Dev S; Osborne NH
    Ann Vasc Surg; 2016 Aug; 35():130-7. PubMed ID: 27311949
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Readmission Rates After Passage of the Hospital Readmissions Reduction Program: A Pre-Post Analysis.
    Wasfy JH; Zigler CM; Choirat C; Wang Y; Dominici F; Yeh RW
    Ann Intern Med; 2017 Mar; 166(5):324-331. PubMed ID: 28024302
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The Impact of the Hospital Readmissions Reduction Program across Insurance Types in California.
    Zingmond DS; Liang LJ; Parikh P; Escarce JJ
    Health Serv Res; 2018 Dec; 53(6):4403-4415. PubMed ID: 29740816
    [TBL] [Abstract][Full Text] [Related]  

  • 50. What is the value of adding Medicare data in estimating VA hospital readmission rates?
    O'Brien WJ; Chen Q; Mull HJ; Shwartz M; Borzecki AM; Hanchate A; Rosen AK
    Health Serv Res; 2015 Feb; 50(1):40-57. PubMed ID: 25040588
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Readmissions and costs among younger and older adults for targeted conditions during the enactment of the hospital readmission reduction program.
    Lu CH; Clark CM; Tober R; Allen M; Gibson W; Bednarczyk EM; Daly CJ; Jacobs DM
    BMC Health Serv Res; 2021 Apr; 21(1):386. PubMed ID: 33902569
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hospitals with higher nurse staffing had lower odds of readmissions penalties than hospitals with lower staffing.
    McHugh MD; Berez J; Small DS
    Health Aff (Millwood); 2013 Oct; 32(10):1740-7. PubMed ID: 24101063
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Accounting for the Growth of Observation Stays in the Assessment of Medicare's Hospital Readmissions Reduction Program.
    Sabbatini AK; Joynt-Maddox KE; Liao JM; Basu A; Parrish C; Kreuter W; Wright B
    JAMA Netw Open; 2022 Nov; 5(11):e2242587. PubMed ID: 36394872
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hospital Readmissions Reduction Program and Post-Acute Care: Implications for Service Delivery and 30-Day Hospital Readmission.
    Li CY; Karmarkar A; Lin YL; Kuo YF; Ottenbacher KJ
    J Am Med Dir Assoc; 2020 Oct; 21(10):1504-1508.e1. PubMed ID: 32660855
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The Long-Term Effect of Financial Penalties on 30-Day Hospital Readmission Rates.
    Lachar J; Avila CJ; Qayyum R
    Jt Comm J Qual Patient Saf; 2023 Oct; 49(10):521-528. PubMed ID: 37394398
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Further Evidence on the System-Wide Effects of the Hospital Readmissions Reduction Program.
    Demiralp B; He F; Koenig L
    Health Serv Res; 2018 Jun; 53(3):1478-1497. PubMed ID: 28480598
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Which Clinical and Patient Factors Influence the National Economic Burden of Hospital Readmissions After Total Joint Arthroplasty?
    Kurtz SM; Lau EC; Ong KL; Adler EM; Kolisek FR; Manley MT
    Clin Orthop Relat Res; 2017 Dec; 475(12):2926-2937. PubMed ID: 28108823
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Is the Hospital Value-Based Purchasing Program Associated with Reduced Hospital Readmissions?
    Beauvais B; Whitaker Z; Kim F; Anderson B
    J Multidiscip Healthc; 2022; 15():1089-1099. PubMed ID: 35592815
    [TBL] [Abstract][Full Text] [Related]  

  • 59. What is the impact of a clinically related readmission measure on the assessment of hospital performance?
    Khouri RK; Hou H; Dhir A; Andino JJ; Dupree JM; Miller DC; Ellimoottil C
    BMC Health Serv Res; 2017 Nov; 17(1):781. PubMed ID: 29179718
    [TBL] [Abstract][Full Text] [Related]  

  • 60. California safety-net hospitals likely to be penalized by ACA value, readmission, and meaningful-use programs.
    Gilman M; Adams EK; Hockenberry JM; Wilson IB; Milstein AS; Becker ER
    Health Aff (Millwood); 2014 Aug; 33(8):1314-22. PubMed ID: 25092831
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.